This information was published on 2020-08-05T14:28:42 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2079220 (IR 1523229) |
| (220) |
29 Jan 2020
|
| (300) |
US, 29 Jul 2019, 88546557
|
| (511) (510) |
Class 5
Drug delivery agents consisting of polymer compounds that facilitate delivery of pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for the treatment of ocular diseases and conditions. |
| (540) | EYEPOINT |
| (550) | Word |
| (730) |
EYEPOINT PHARMACEUTICALS US, INC.
|
Find out more about publications on the About page.